Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer :A Randomized, Open, Parallel, Multicentre, Phase Ⅲ Study
Latest Information Update: 06 Nov 2021
Price :
$35 *
At a glance
- Drugs Docetaxel (Primary) ; Nedaplatin (Primary) ; Cisplatin
- Indications Squamous cell cancer
- Focus Therapeutic Use
- 05 Dec 2017 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Dec 2015).
- 03 Feb 2016 New trial record